Respiratory motion-corrected proton magnetic resonance spectroscopy of the liver

Magnetic Resonance Imaging

Volumn 27, Issue 4, 2009, Pages 570-576

  Noworolski, Susan M ^a   Tien, Phyllis C ^b   Merriman, Raphael ^c   Vigneron, Daniel B ^a   Qayyum, Aliya ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Liver; Motion correction; Nonalcoholic fatty liver disease; Respiration; Spectroscopy; Steatosis

Indexed keywords

LIPID; WATER;

ADULT; ALGORITHM; ARTICLE; BREATHING; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INCIDENCE; LIVER; MAJOR CLINICAL STUDY; MALE; MONITORING; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RESPIRATORY SYSTEM; SIGNAL NOISE RATIO; TIME SERIES ANALYSIS;

ADULT; ALGORITHMS; ARTIFACTS; FATTY LIVER; FEMALE; HEPATITIS C; HUMANS; LIPIDS; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROTONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

HEPATITIS C VIRUS;

EID: 63349110696     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2008.08.008     Document Type: Article

References (32)

1. Neuschwander-Tetri B.A., and Caldwell S.H. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37 5 (2003) 1202-1219
2. Scheen A.J., and Luyckx F.H. Obesity and liver disease. Best Pract Res Clin Endocrinol Metab 16 4 (2002) 703-716
3. Hadigan C., Liebau J., Andersen R., Holalkere N.S., and Sahani D.V. Magnetic resonance spectroscopy of hepatic lipid content and associated risk factors in HIV infection. J Acquir Immune Defic Syndr 46 3 (2007) 312-317
4. Gaslightwala I., and Bini E.J. Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection. J Hepatol 44 6 (2006) 1026-1032
5. McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 2004;8(3):521-33, viii.
6. Poynard T., Bedossa P., and Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349 9055 (1997) 825-832
7. Clouston A.D., Jonsson J.R., and Powell E.E. Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others. Clin Liver Dis 11 1 (2007) 173-189
8. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 6 (2005) 1313-1321
9. Huang M.A., Greenson J.K., Chao C., et al. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol 100 5 (2005) 1072-1081
10. Neuschwander-Tetri B.A., Brunt E.M., Wehmeier K.R., Oliver D., and Bacon B.R. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology 38 4 (2003) 1008-1017
11. Federico A., Niosi M., Vecchio Blanco C.D., and Loguercio C. Emerging drugs for non-alcoholic fatty liver disease. Expert Opin Emerg Drugs 13 1 (2008) 145-158
12. Rosen B.R., Carter E.A., Pykett I.L., Buchbinder B.R., and Brady T.J. Proton chemical shift imaging: an evaluation of its clinical potential using an in vivo fatty liver model. Radiology 154 (1985) 469-472
13. Bollard M.E., Garrod S., Holmes E., et al. High-resolution (1)H and (1)H-(13)C magic angle spinning NMR spectroscopy of rat liver. Magn Reson Med 44 2 (2000) 201-207
14. Foley L.M., Towner R.A., and Painter D.M. In vivo image-guided (1)H-magnetic resonance spectroscopy of the serial development of hepatocarcinogenesis in an experimental animal model. Biochim Biophys Acta 1526 3 (2001) 230-236
15. Thomsen C., Becker U., Winkler K., Christoffersen P., Jensen M., and Henriksen O. Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 12 3 (1994) 487-495
16. Longo R., Pollesello P., Ricci C., et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 5 3 (1995) 281-285
17. Szczepaniak L.S., Babcock E.E., Schick F., Dobbins R.L., Garg A., Burns D.K., et al. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 276 5 Pt 1 (1999) E977-E989
18. 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 28 4 (1993) 297-302
19. Noworolski S.M., Tien P., Westphalen A., Merriman R., Vigneron D.B., and Qayyum A. MR Spectroscopy of non-alcoholic fatty liver disease. Proc Int Soc Magn Reson Med 11 (2005) [abstract 336]
20. Thomas E.L., Hamilton G., Patel N., O'Dwyer R., Dore C.J., Goldin R.D., et al. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 54 1 (2005) 122-127
21. Barkan S.E., Melnick S.L., Preston-Martin S., et al. The Women's Interagency HIV Study. Epidemiology 9 (1998) 117-125
22. Bacon M.C., von Wyl V., Alden C., et al. The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol 12 (2005) 1013-1019
23. Zhu G., Gheorghiu D., and Allen P.S. Motional degradation of metabolite signal strengths when using STEAM: a correction method. NMR Biomed 5 4 (1992) 209-211
24. 1H magnetic resonance spectroscopy. Magn Reson Med 43 3 (2000) 325-330
25. Gabr R.E., Sathyanarayana S., Schar M., Weiss R.G., and Bottomley P.A. On restoring motion-induced signal loss in single-voxel magnetic resonance spectra. Magn Reson Med 56 4 (2006) 754-760
26. Helms G., and Piringer A. Restoration of motion-related signal loss and line-shape deterioration of proton MR spectra using the residual water as intrinsic reference. Magn Reson Med 46 2 (2001) 395-400
27. 1H MR spectroscopy. Radiology 229 2 (2003) 587-592
28. Nelson S., and Brown T. A new method for automatic quantification of 1-D spectra with low signal to noise ratio. J Magn Reson Imaging 84 (1987) 95-109
29. Nelson S.J. Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors. Magn Reson Med 46 2 (2001) 228-239
30. Schwarz A., and Leach M. Implications of respiratory motion for the quantification of 2D MR spectroscopic imaging data in the abdomen. Phys Med Biol 45 8 (2000) 2105-2116
31. Merriman R.B., Ferrell L.D., Patti M.G., Weston S.R., Pabst M.S., Aouizerat B.E., et al. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 44 4 (2006) 874-880
32. Katz-Brull R., Rofsky N.M., and Lenkinski R.E. Breathhold abdominal and thoracic proton MR spectroscopy at 3T. Magn Reson Med 50 3 (2003) 461-467